精彩推荐:青光眼 白内障 近视 远视 散光 斜视弱视 角膜溃疡 角膜炎 沙眼 眼外伤 更多疾病
大众频道
专业频道
时尚频道
互动频道
疾 病 | 保 健 | 爱眼动态 | 名医名院
知 识 | 美 食 | 自检自测 | 爱眼纪事
资 讯 | 临 床 | 学 术 | 文 献
图 谱 | 医 患 | 继 教 | 家 园
五官之美 | 整 形 | 美 容
眼镜一族 | 妆 容 | 图 库
眼科在线 | 预留位置
眼科知道 | 在线咨询
  当前位置:当前位置: 中华眼科在线 → 医学频道 → 学术论文汇编 → WOC2008 → 正文 切换到繁體中文 用户登录 新用户注册
Established optic nerve glioma cell lines immortalized by SV40 Large T-antigen

http://www.cnophol.com 2009-4-27 15:19:45 中华眼科在线

李永平

中山大学中山眼科中心510060

ABSTRACT Objective To establish immortalized human Optic Nerve Glioma cell lines in vitro for the further related research on the differentiation mechanism and regulation of tumorigenesis in human central nervous system. Methods By using LipofectamineTm2000, a gene transfection reagent, plasmid tgLS(+)LoxPHyTKcmvLT containing the simian virus 40 large T-antigene gene ( SV40Tag) was transfected into the primary cultured Optic Nerve Glioma. Colonies were isolated by Hygromycin selection and expanded by more than 50 passages. Investigate the capability of differentiation of the transfected cells with growth curve by methyl thiagolyl totrayolum experiment. The expression of SV40Tag in expanded cell lines was identified by immunocytochemistry stain,transmission electron microscope and RT-PCR. Results Particular anti- Hygromycin cell clones were acquired which can be repassaged for more than 50 passages. The total RNA were isolated from the positive cell clones, and a 372 bp fragment, which was specific for the SV40T antigene gene, was amplified. The transfected cells were expanded to immortalized cell strain. Conclusion Human optic nerve glioma cells could be cultured in vitro, and immortalized through the transfection of retroviral vector containing SV40 LT antigen.


声明:本站独家报道,转载须标明来源“中华眼科在线”

 


 

(来源:中华眼科在线)(责编:zhanghui)

发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
  • 下一条信息: 没有了
  • 更多关于(眼睛,中华眼科在线,woc2008世界眼科学术大会,中华医学会第13届全国眼科学术大会,眼科病理,视力)的信息
      热门图文

    决定女人健康的14个部

    祛除鱼尾纹so easy

    增加眼睛明亮度的八个

    张梓琳全新清新性感熟
      健康新看点
      健康多视点
      图话健康

    Copyright © 2007 中华眼科在线 网站备案序列号: 京ICP备08009675号
    本网站由五景药业主办 北京金鼎盛世医学传媒机构负责运营 国家医学教育发展中心提供学术支持
    服务电话:010-63330565 服务邮箱: [email protected]